Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
102.02
+0.47 (0.46%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,800 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,800
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,453,196
Profits / Employee
$200,043
Market Cap
6.24B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
JAZZ News
- 9 days ago - Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out - Seeking Alpha
- 10 days ago - Jazz Pharma to pay $145 million to settle narcolepsy drug antitrust case - Reuters
- 23 days ago - Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 4 weeks ago - Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting - PRNewsWire
- 5 weeks ago - CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire
- 6 weeks ago - Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga
- 6 weeks ago - Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters
- 6 weeks ago - Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio - GlobeNewsWire